Scleritis and Endophthalmitis Due to Streptococcus pyogenes Infective Endocarditis

Am J Med. 2020 Jan;133(1):e15-e16. doi: 10.1016/j.amjmed.2019.07.015. Epub 2019 Jul 26.

Authors

Hayato Mitaka¹, Tessa Gomez², David C Perlman²

Affiliations

¹ Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: hayato.mitaka@mountsinai.org.
² Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY.

PMID: 31351838
DOI: 10.1016/j.amjmed.2019.07.015

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Ceftazidime / therapeutic use
Echocardiography
Endocarditis, Bacterial / complications
Endocarditis, Bacterial / diagnostic imaging*
Endocarditis, Bacterial / therapy
Endophthalmitis / diagnosis*
Endophthalmitis / drug therapy
Endophthalmitis / etiology
Humans
Intravitreal Injections
Magnetic Resonance Imaging
Male
Mitral Valve / diagnostic imaging
Mitral Valve / surgery
Mitral Valve Insufficiency / diagnostic imaging
Mitral Valve Insufficiency / etiology
Mitral Valve Insufficiency / surgery
Scleritis / diagnosis*
Scleritis / drug therapy
Scleritis / etiology
Streptococcal Infections / complications
Streptococcal Infections / diagnosis*
Streptococcal Infections / drug therapy
Streptococcus pyogenes
Vancomycin / therapeutic use

Substances

Anti-Bacterial Agents
Vancomycin
Ceftazidime